Quebec - Bausch Health Companies Inc. (NYSE/TSX: BHC) will release first-quarter 2024 financial results on Thursday, May 2, 2024.

Bausch Health will host a conference call and live webcast at 8:00 a.m. U.S. EST to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call.

Conference Call Details

Date: Thursday, May. 02, 2024

Time: 8:00 a.m. U.S. EDT

Webcast: http://ir.bauschhealth.com/events-and-presentations

A replay of the conference call will be available on the investor relations website.

To participate in the live Q&A session, please register using this link to receive a PIN, which will be sent an hour before the conference call.

About Bausch Health

Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health outcomes. We develop, manufacture and market a range of products, primarily in gastroenterology, hepatology, neurology, dermatology, medical aesthetic devices, international pharmaceuticals, and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors.

Contact:

Garen Sarafian

Email: ir@bauschhealth.com

Tel: (877) 281-6642

Kevin Wiggins

Email: corporate.communications@bauschhealth.com

Tel: (908) 541-3785

(C) 2024 Electronic News Publishing, source ENP Newswire